The drugs, from a class of digestion-slowing medicines known as GLP-1 agonists, have eaten into demand at some big companies, ...

Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The ...

Here's the list of options activity happening in today's session: These bullet-by-bullet explanations have been constructed using the accompanying table. • For MRK MRK, we notice a put option sweep ...

The request follows a similar move by Eli Lilly, which has asked for a ban on other parties making copies of its tirzepatide-based therapies Mounjaro for diabetes and Zepbound for obesity ...